Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variable resistance to palivizumab in cotton rats by respiratory syncytial virus mutants.

The Journal of infectious diseases - 1 Dec 2004

Zhao Xiaodong, Chen Fu-Ping, Megaw A George, Sullender Wayne M

Abstract excerpt

BACKGROUND: Palivizumab (PZ) is the only monoclonal antibody in use against a human infectious disease. PZ is given as prophylaxis against infection with respiratory syncytial virus (RSV). An RSV escape mutant, MP4, has been shown to resist PZ prophylaxis in cotton rats. METHODS: To further defin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Monoclonal, Humanized
Share to Injections, Intramuscular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neutralization Tests

Share to Respiratory Syncytial Virus Infections

Share to Respiratory Syncytial Viruses

Share to Sigmodontinae

Share to Viral Fusion Proteins

Source

Identifiers

PMID: 15529258
DOI: 10.1086/425515

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15529258-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variable resistance to palivizumab in cotton rats by respiratory syncytial virus mutants.PMID 15529258Read ↗

Respiratory syncytial virus escape mutant derived in vitro resists palivizumab prophylaxis in cotton rats.Semantic proximity Read ↗

In Vivo Selection of Respiratory Syncytial Viruses Resistant to PalivizumabSemantic proximity Read ↗

In vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants.Semantic proximity Read ↗

Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab.Semantic proximity Read ↗

Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.Semantic proximity Read ↗

Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis.Semantic proximity Read ↗

Palivizumab‐Resistant Human Respiratory Syncytial Virus Infection in InfancySemantic proximity Read ↗

Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals modelsSemantic proximity Read ↗

Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.Semantic proximity Read ↗

SVMPA, a mutant of sindbis virus resistant to mycophenolic acid and ribavirin, shows an increased sensitivity to chick interferon.Semantic proximity Read ↗

Characterization of a spontaneous drug-resistant mutant of monkey B virus (Macacine herpesvirus 1).Semantic proximity Read ↗

Evolution of protection after maternal immunization for respiratory syncytial virus in cotton ratsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.